HN015 A PHASE II RANDOMIZED TRIAL OF NEOADJUVANT CHEMOTHERAPY OR CHEMO-IMMUNOTHERAPY IN PATIENTS WITH RECURRENT/PERSISTENT PD-L1 ENRICHED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK UNDERGOING SALVAGE SURGERY (NEOPOLIS)



Mary Beth Wilwerding, RN Admin@NEcancertrials.com



Available at Nebraska Methodist Estabrook Cancer Center

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*

Email*

Phone*

Message*